MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 06-29-2023
Idera Pharmaceuticals PEG Ratio 2011-2026 | IDRA
Annual PEG Ratio Idera Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.000443 | 0.000116 | -0.134 | -0.0275 | 0.0356 | -0.11 | 0.157 | 0.432 | 4.65 | 0.244 | 0.0484 | -0.0278 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.65 | -0.134 | 0.439 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Compugen Ltd.
CGEN
|
0.0951 | $ 2.86 | 3.62 % | $ 267 M |  Israel |
 |
FSD Pharma
HUGE
|
0.0115 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M |  China |
 |
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
-0.232 | $ 0.8 | -3.59 % | $ 36.6 M | Israel |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | USA |
 |
Exelixis
EXEL
|
-2.14 | $ 46.21 | -5.11 % | $ 12.5 B | USA |
 |
Fortress Biotech
FBIO
|
0.044 | $ 2.4 | -5.88 % | $ 67 M | USA |
 |
BioNTech SE
BNTX
|
-12.8 | $ 93.02 | -2.35 % | $ 27.2 B | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
|
Forte Biosciences
FBRX
|
0.00783 | $ 26.17 | -1.32 % | $ 339 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
0.189 | - | - | $ 231 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
-0.144 | $ 22.56 | 5.03 % | $ 3.74 B | USA |
 |
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | USA |
 |
Esperion Therapeutics
ESPR
|
0.799 | $ 3.14 | -0.32 % | $ 653 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.54 | 3.51 % | $ 5.83 M | Israel |
 |
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | Canada |
 |
Genprex
GNPX
|
-0.000095 | $ 0.87 | -2.84 % | $ 811 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | USA |
 |
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
6.77 | $ 20.66 | -14.52 % | $ 2.63 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-0.0713 | - | 3.16 % | $ 1.9 M | USA |
 |
Genmab A/S
GMAB
|
0.277 | $ 27.06 | -2.98 % | $ 16.7 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | USA |
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
4.18 | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
-0.00319 | - | 10.36 % | $ 9.8 M | USA |
 |
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | USA |
 |
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
-7.82 | - | 17.91 % | $ 11.1 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
0.0973 | $ 52.42 | -4.83 % | $ 4.71 B |  Schweiz |
 |
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.61 | -5.29 % | $ 428 M | Britain |
 |
Heron Therapeutics
HRTX
|
-0.000562 | $ 1.24 | -5.34 % | $ 207 M | USA |
 |
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | USA |